CITI/CALL/CSPC PHARMACEUTICAL GROUP/7.7/0.2/21.11.24 | Market Closed - Hong Kong S.E. 09:00:00 16/07/2024 BST | ||
| 0.027 HKD | -10.00% |
|
| Current month | -37.21% | ||
| 1 month | -68.97% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about CSPC PHARMACEUTICAL GROUP LTD.
More news
| Date | Price | Change |
|---|---|---|
| 16/07/24 | 0.027 | -10.00% |
| 15/07/24 | 0.03 | -14.29% |
| 12/07/24 | 0.035 | +9.38% |
| 11/07/24 | 0.032 | +14.29% |
| 10/07/24 | 0.028 | -12.50% |
Delayed Quote Hong Kong S.E.
Last update July 16, 2024 at 09:00 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | CSPC PHARMACEUTICAL GROUP LTD. |
| Issuer | 
Citi
|
| ISIN | DE000KH6GZ30 |
| Date issued | 12/07/2023 |
| Strike | 7.7 $ |
| Maturity | 21/11/2024 (128 Days) |
| Parity | 5 : 1 |
| Emission price | 0.25 $ |
| Emission volume | N/A |
| Settlement | cash |
| Currency | HKD |
Technical Indicators
| Highest since issue | 0.248 $ |
|---|---|
| Lowest since issue | 0.027 $ |
| Spread | 0.001 $ |
| Spread % | 3.70% |
Company Profile
CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows:
- drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%);
- vitamin C (10.1%);
- antibiotics (6.2%);
- other (5%): including anhydrous and raw caffeine.
Net sales are distributed geographically as follows: China (82.8%), Asia (7.2%), Europe (4.6%), the Americas (4.4%) and others (1%).
Sector
-
Ratings for CSPC Pharmaceutical Group Ltd.
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: CSPC Pharmaceutical Group Ltd.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
5.99
HKD
Average target price
9.562
HKD
Spread / Average Target
+59.64%
- Stock Market
- Warrants
- Warrant
